BioSyent (OTCMKTS:BIOYF) Trading 2.1% Higher – Still a Buy?

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report) was up 2.1% during mid-day trading on Thursday . The company traded as high as $9.28 and last traded at $9.28. Approximately 700 shares traded hands during mid-day trading, a decline of 28% from the average daily volume of 975 shares. The stock had previously closed at $9.09.

BioSyent Trading Down 0.1%

The company’s fifty day moving average price is $8.51 and its 200 day moving average price is $8.44.

BioSyent Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, December 1st were given a dividend of $0.0356 per share. The ex-dividend date was Friday, November 28th. This represents a dividend yield of 183.0%.

BioSyent Company Profile

(Get Free Report)

BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.

BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.

See Also

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.